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INTRODUCTION 
 
 
 
 
  
  INTRODUCTION  
 For small organic molecules, simple nitrogen containing heterocyclic receive a 
large amount of attention in the literature, as a consequence of their exciting biological 
properties and they role as pharmacophores of considerable historical importance. 
 Hetero cyclic compounds are stable cyclic compounds in which at least one atom 
other than carbon forms a part of the ring. The hetero atom is mostly nitrogen, oxygen or 
sulphur. The heterocyclic are usually five or six member cyclic compounds 
Dihydropyridine1 is one of the heterocyclic compounds, which is simple 
derivative of pyridine. They are particularly well known in pharmacology as L-type 
calcium channel blockers. They are readily convertible to pyridines and are important 
role as intermediates in reactions of pyridine e.g in nucleophilic substitutions and 
reductions as well as acylations in the presence of pyridine. Dihydropyridines are of 
utmost importance in biological systems especially NADH2 which is involved in the 
biological redox reactions. It is water soluble B complex vitamin. 
N
Pyridine
N
H
1,4-dihydropyridine
N
OH
O
Nicotinic acid  
1, 4-dihydropyridine  
  
Physical properties 
Structure 
                                               
N
H
COOR'
CH3
H3C
"ROOC
R
R-Hydroxy phenyl 
                                                                                                   R’-COOC2H5 
 R’’-COOC2H5 
Description 
Dihydro pyridine is an amphoteric, colourless with a distinctive unpleasant fish-
like odour. The pyridine ring occurs in many important compounds, including 
nicotinamides.Its PH in aqueous saturated solution is 8.5.  
Solubility 
It is freely soluble in boiling water, alcohol, alkali hydroxide, carbonates and in 
propylene glycol .Ii is practically insoluble in diethylether. 
Sources 
It occurs in all living cells in small amounts. 
Chemistry 
            The molecular formula is C5H7N. 
 
  
HANTZSCH DIHYDRO PYRIDINE (PYRIDINE) SYNTHESIS 
N
H
COOR"
CH3
H3C
"ROOC
R
R-CHO + 2 R' OR"
O O
+ NH3
 
This reaction allows the preparation of dihydro pyridine derivatives by 
condensation of an aldehyde with two equivalents of a beta -ketoester in the presence of 
ammonia. Subsequent oxidation (or dehydrogenation) gives pyridine-3, 5-dicarboxylates, 
which may also be decarboxylated to yield the corresponding pyridines. 
Mannich bases2 
  A Mannich base is a β-amino ketone, which is formed by reacting of an amine, 
formaldehyde (or an aldehyde) and a carbon acid. The mannich base is an end product in 
the mannich reaction, which is a nucleophilic addition reaction of a non-enolizable 
aldehyde and primary or secondary amines to produce resonance stabilized imines 
(minimum ion or imines salt). The addition of a compound containing active hydrogen 
atom to the schiff’s base gives the Mannich base. 
 The essential feature of the Mannich reaction is the replacement of the active 
hydrogen atom by an amino methyl group. 
                                                                                      Base or acid 
HN CH3H3C H C
O
H
O
O
H2
CN
H3C
CH3
Di
methylamine              Formaldehyde         Cyclohexanone                 Mannich base 
  
         Mannich bases are important compounds owing to their wide range of biological 
and industrial applications. They are also employed as intermediates in chemical 
synthesis and polymer chemistry. Several important therapeutic compounds have been 
synthesized via the Mannich reaction. They have also been found to possess 
pharmacological activities, such as asanticancer, antiviral, anti-malarial, anti-tubercular, 
anti-bacterial, analgesic, anti-inflammatory activity etc 3. 
Mechanism of the Hantzsch Dihydropyridine synthesis4 
The reaction can be visualized as proceeding through a knoevenagel condensation 
product as a key intermediate. 
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Derivatives of 1, 4-dihyropyridine5,35  
            M1             
N O
O
OO Cl
Cl
Dimethyl1,4-dihydro-4-(3,4-dichlorophenyl)-2,6-dimethyl-1-(3-phenylpropyl)-3,5-pyridine dicarboxylate  
 M2                                                  
N
H2C
COOC2H5
H3C
R'
C2H5OOC
N
CH3
H
SO2NH2
 
3,5-diethoxycarbonyl-1-[(4’-sulfamoyl-1’-aminomethyl)phenyl)-1-4-dihydro-2,6-dimethyl-4-(3’-
methoxy-4’-hydroxy phenyl)-pyridine. 
The dihydropyridine derivatives have variety of pharmacological activities like 
Analgesic, Anti-inflammatory, Anti-fungal, Anti-bacterial, Anti-convulsant, Anti-
hypertensive. 
Due to importance of 1, 4-dihydropyridine derivatives and its isomers, the aim of 
this dissertation is to evaluate the invitro antioxidant activity and antimicrobial activity 
against staphylococcus auereus of several compounds of this class. 
  
REVIEW OF LITERATURE 
Bu chanan et al6., synthesised the structures of a number of  mannich bases which have 
been checked by NMR1 the deshielding effect of N-protonation being used to identify 
adjacent protons.whilist mannich bases lacking a beta- proton can react Michael- wise via 
a rearrangement, but their quaternary methiodides do not. On this evidence, anomalous 
literature reports can be rationalized. 
Jungjin suh et al7., synthesised and carried out the anti hypertensive activity of 4-(2,4-
Dioxo-5-pyrimidyl)-1,4-dihydro pyridine. 
                                             
HN NH
O
O
N
H
COOR2 COOR2
R-C2H5 
Denner et al8., synthesised and carried out biological evaluation of new 1, 4-dihydro 
pyridines as anti-hypertensive agents in rats. 
Kawashima.Y et al9., synthesised and performed anti-hypertensive activities of 1, 4-
dihydropyridine-5-phosphonate derivatives. 
JAM Christians et al10., synthesised and carried out in vitro pharmacology of new 1,4-
dihydropyridines.2-(w-aminoalkylthiomethyl)-1,4-dihydropyridines as potent calcium 
channel blockers. 
  
J M Vierfond et al11.,reported the synthesis, binding affinity and antioxidant activity of 
1,4-dihydropyridine. 
N
H
H
OC-O-C2H5
H3C Ar2
Ar1
R
 
M.Amir et al12., reported 6-phenyl-1, 4-dihydro pyridine derivatives as potent and 
selective A3- adenosine receptor antagonist. 
Kotecka et al13.,we had compared the ex-vivo anti-malarial activity of 12 new quinoline 
di-mannich base compounds containing the 7-dichloroquinoline (or) 7-trifluoro 
methylquinoline nucleus with amodiaquine, chloroquine and pyronaridine using the 
saimiri- bioassay model.In vitro activity against the multi drug-resistantK1 isolate of 
plasmodium falciparum was determined in serum samples by measuring the maximum 
inhibitory dilution at which the treated monkey serum inhibited schizont maturation in 
vitro of the 12 mannich bases tested, 8 were associated with levels of ex-vivo anti-
malarial activity in serum greater than those of amodiaquine, chloroquine, or 
pyronaridine 1to 7 days after drug administration. Further studies were carried out with 
four of these compounds, and results showed. 
G.Diaz-Araya et al14., synthesised and carried out the antioxidant effects of 1,4-dihydro 
pyridine and Nitroso aryl derivatives on the Fe3+/ascorbate- stimulated lipid per 
oxidation in rat brain slice. 
R- H 
Ar1 -2-pyrazinyl 
Ar2 -2-pyrazinyl 
  
Tirzitis et al15.,synthesised some 2, 6-dimethyl-3, 5-dialkoxy carbonyl-1,4-dihydro 
pyridines in metal-ion catalyzed lipid per oxidation and screened for antioxidant activity.                                
                                      
N
R'H
COOR
CH3
H3C
ROOC
H R-H 
                                                                                                 R’-OCH3     
Kruk et al16.,performed the antioxidant activity of 4-flavonil-1, 4-dihydro pyridine 
derivatives. 
O
O
N-H
CH3COR2
CH3COR1
R1 – OCH3 
                                                                                                        R2 – OCH3 
Pandeya et al17.,synthesised and done the spectral characterization, in vitro antibacterial 
and antifungal activities of N-mannich bases of 3(N-pyrimethaminylimino) isatin. 
Khan et al18.,studied the mechanism- based inactivation of thioredoxin reductase from 
plasmodium falciparum by mannich bases implication for cytotoxicity. 
 
  
Shafiee et al19.,reported the anticonvulsant activities of new 1, 4-dihydropyridine 
derivatives containing 4-nitroimidazolyl substituents. 
N
N CH3
NO2
N
H
CH3H3C
R2OOC
COOR1
 R1-CH 2C6H5           
            R2- CH3 
Lopes et al20.,synthesised some novel N-mannich base-type derivatives of  the 
antimalarial drug  amodiaquine and their reaction with tertiary N-chloromethylamides 
with the exception of the derivative of ethyl hippurate, all the so-formed (1-amidomethl-
1H-quinolin-4-ylidine) arylamines displayed high  chemical and enzymatic stability. 
These compounds displayed antimalarial activity against the multi-drug resistant 
plasmodium falciparum strain Dd2 (IC 50 values 15-31nm) and demonstrated no 
significant loss in activity compared to amodiaquine. 
Dinh Thanh Hai et al21.,synthesised (5-nitrofurfural and m-nitro benzaldehydes) by the 
condensation of aromatic aldehydes with hydantoin. The derivatives I and VI were 
obtained. The compounds I VI underwent mannich reaction and gave 8 mannich base 
derivatives (II-V, VII-X). The structures of synthesised compounds have been 
characterized by IR, UV, and 1H-NMR, 13C-NMR and mass spectroscopy. The obtained 
compounds were tested for biological activities such as antibacterial, antifungal and 
anticancer. Compounds I and its mannich base derivatives showed high biological 
activities. 
 
  
R.Sridhar, P.T.Perumal et al22.,reported a new protocol to synthesize 1,4-
dihydropyridines by using 3, 4, 5-trifluorobenzenboronic acid as a catalyst in ionic liquid 
and synthesis of novel 4-(3-carboxyl-1H-pyrazol-4-yl)-1,4-dihydropyridines. 
R.Budriesi et al23.,synthesised the 1,4-dihydropyridine derivatives as calcium channel 
modulators: the role of 3-methoxy- flavones moiety was found to be angina and 
antihypertensive activity.                                                                            
                                                 
O
R1
O
OCH3
 R1-CH2CH=CH2 
Negm Nobel’s et al24.,prepared some novel series of cationic surfactants based on 
mannich base (produced from the condensation of piperidine and / or morpholine as 
secondary amine and para formaldehyde in  the presence of 8- hydroxyl quinoline).The 
chemical structures of the synthesised cationic surfactants were confirmed using 
elemental analysis, FTIR  spectroscopy and 1H NMR. Surface activities of the prepared 
surfactants were measured including surface tension (gamma), critical micelle 
concentration effectiveness (Pi(cmc)), efficiency(Pc 20), maximum  surface excess 
(Gamma(max), minimum surface area(A(min), interfacial tension(gammaIT)), 
emulsification power and foaming power at 25˚c. The structural influences on their 
surface activities and adsorption free energy were discussed. 
  
A.K.Chhillar et al25.,reported microwave-assisted synthesis of antimicrobial 
dihydropyridines and tetrahydropyrimidin-2-ones and some novel compounds against 
aspergillus’s niger. 
                                              
R1
R2
R3
N CH3
COOCH3
CH3
H3COOC
H  R1- OCH3 
                                                                                                         R2-H 
                                                                                                         R3-H 
F.Mustata L.Bicu et al26.,synthesised and characterization of p-amino benzoic 
acid/Cyclohexanone/formaldehyde resins as hardner for epoxy resins.  
M.A. Zolfigol et al27.,synthesised iodine catalyzed synthesis of novel hantzsch N-
hydroxyethyl 1,4-dihydropyridines under mild conditions. 
SR Pattan et al28.,the synthesised and evaluation of some new substituted 1,4-
dihydropyridine derivatives and their anti-inflammatory activity. 
O
R1
O
OCH3
 R1-CH2CH=CH2 
V.Sridharan et al29.,synthesised some new 3-component domino of 1,4-
dihydropyridines. 
  
                                          
N
R1
Z
O
CH3
R5
R4
R3
R2
    R1-H 
                                                                      R2-OCH3 
                                                                      R3-CH3 
                                                                      R4-CH3  
                                                                      R5-CH3      
R. Leon et al30.,synthesised 6-amino-1,4-dihydropyridines that prevent calcium overload 
and neuronal death to posses antihypertensive activity. 
                                             
N
N
H
CN
NH2
O
 
J Carbajo et al31.,synthesised and carried antihypertensive activity of some  
C-substituted 2, 6-dimethyl-1,4-dihydropyridines. 
M. Ashok et al32.,performed convenient one pot synthesis and antimicrobial evaluation 
of some new mannich bases carrying 4-methylthio benzyl moiety. 
Belle Ds and Singhvi et al33.,performed synthesis and antimicrobial activity of some 
mannich bases of 6-substituted-2-amino benzothiazole.  
Rakeshkumar et al34., synthesised and performed antimicrobial activity of 4-(5-chloro -
3-methyl-1-phenyl-1H-pyrazol-4-yl)–dihydropyridines and 4-(5-chloro -3-methyl-1-
phenyl- 1H-pyrazol-4-yl) – 3,4-dihydropyrimidin-2-ones. 
  
BBSubudhi et al35.,performed the synthesis and antiulcer activity study of 1,4-
dihydropyridines and their mannich bases with sulphanilamide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
OBJECTIVE AND PLAN OF WORK 
 The Dihydropyridine have already proven to have variety of pharmacological 
activities like analgesic, anti-inflammatory, anti-fungal, anti-bacterial, anti-oxidant, anti-
convulsant, anti-hypertensive, anti-ulcer, calcium channel antagonist, anti-tumor activity 
and many more activities. 
Therefore, based on the previously reported information concerning 1,4.-dihydro 
pyridine derivatives, I have planned to synthesize some new 1,4dihydro pyridine 
derivatives with different aldehyde with more biological and chemotherapeutic efficacy 
as compared to some previously reported dihydro pyridine derivatives with good yield. 
            So an attempt was made to synthesize dihydro pyridine derivatives and prove 
their anti-oxidant and anti-microbial activities. The current study contains the following 
¾ Synthesis of 1,4-dihydropyridine derivatives. 
¾ Synthesis of mannich base of 1, 4- dihydropyridine derivatives. 
¾ Characterization of synthesised compounds. 
¾ Screening for Biological Activity 
          a)  Anti-oxidant activity   
          b)  Anti-microbial 
  
PLAN OF WORK  
Synthesis of the 1,4- dihydro pyridine was carried out in following steps 
             Step.1  
¾ Synthesis of 1,4-dihydropyridine derivatives. 
              Step.2 
¾ Synthesis of mannich base of 1,4- dihydropyridine derivatives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
SCHEME OF THE WORK 
Step 1 
         
C2H5OOC CH2
C
OCH3
C2H5OOC CH2
C
OCH3
RCHO
N
H
COOC2H5
CH3H3C
R'
C2H5OOC
3hr
Ethyl aceto acetate
concNH4OH
+
 
                                                 R=C8H7 ,  3,4-OCH3-C6H4,   2-4-Cl-C6H4,                    
                                          4-CH3-C6H4,   2-OCH3-4-OH-5-OCH3-C6H2 
 
  
Step 2 
N
H
COOC2H5
CH3H3C
R'
C2H5OOC
(i)HCHO/EtOH
(ii) COOHNH2
P-amino bezoic acid
N
H2C
COOC2H5
H3C
R'
C2H5OOC
N
CH3
H
COOH
4hour
Mannich base of 1,4-dihydropyridine derivatives  
                                                 R=C8H7 ,  3,4-OCH3-C6H4,   2-4-Cl-C6H4,                    
                                                      4-CH3-C6H4,   2-OCH3-4-OH-5-OCH3-C6H2 
 
 
 
 
 
 
 
 
 
 
 
 
  
 EXPERIMENTAL WORK  
 
Table 1  
 
LIST OF CHEMICALS 
S. No. CHEMICALS USED MANUFACTURES 
1 Ethyl aceto acetate Chemlabs 
2 Ethanol Chemlabs 
3 Ammonia Chemlabs 
4 P-Tolualdehyde Himedia 
5 Cinnamaldehyde Himedia 
6 2,4-dichloro benzaldehyde Himedia 
7 Veratraldehyde Himedia 
8 Syringaldehyde Himedia 
 
  
Apparatus; Beaker, conical flask, round bottom flask, condenser made of Borosil glass, 
funnel, vaccum filter, magnetic stirrer. 
PROCEDURE 
Step I  Preparation of the 1,4-dihydropyridine derivatives  
General procedure   
 A mixture of aldehyde (0.2mole), ethyl acetoacetate (0.2mole) and concentrated 
ammonium hydroxide (8 ml) in ethanol (60ml) was heated under reflux for 3 hours. To 
the resulting mixture, warm water (40 ml) was added and then allowed to cool. The 
separated product was filtered off, washed with 60% aqueous ethanol and recrystallized 
from alcohol to give Product and it is used for the further reaction (compound 1a).         
N
H
COOC2H5
CH3H3C
R'
C2H5OOC
C2H5COO
CH2
C
H2C
O
+
CH2
C2H5OOC
CH
OCH2
RCHO
Ethanol
3hour
Ethylacetoacetate
Conc.NH4OH
 
                                 Where,                       
                                                    R=C8H7 ,  3,4-OCH3-C6H4,   2-4-Cl-C6H4,                    
                                       4-CH3-C6H4,   2-OCH3-4-OH-5-OCH3-C6H2 
 
  
Similarly, compounds (1a-e) were prepared by condensation of ethylacetoacetate and 
ammonium hydroxide with other aromatic aldehyde. 
Step II  Preparation of 1,4-dihydropyridine derivatives  
 A mixture of compound Ia, p-aminobenzoic acid (0.01 mole) and p-formaldehyde 
(0.02 mole) was taken in 15 ml of rectified spirit and heated under reflux for 4 hours. The 
reaction mixture was poured on to crushed ice. The product was filtered and 
recrystallized from aqueous ethanol to give product (compound 2a). 
N
H
COOC2H5
CH3H3C
R'
C2H5OOC
(i)HCHO/EtOH
(ii) COOHNH2
P-amino bezoic acid
N
H2C
COOC2H5
H3C
R'
C2H5OOC
N
CH3
H
COOH
4hour
Mannich base of 1,4-dihydropyridine derivatives
 
                                                     Where,                       
                                                    R=C8H7 ,  3,4-OCH3-C6H4,   2-4-Cl-C6H4,                    
                                                         4-CH3-C6H4,   2-OCH3-4-OH-5-OCH3-C6H2 
  
Similarly, compounds (2a-e) were prepared by condensation of p-aminobenzoic acid and 
p-formaldehyde with product (1a-e). 
 
SYNTHESISED DERIVATIVES 
1a              
                                 
N
H
COOC2H5
CH3H3C
C2H5OOC
CH
CH
  
Diethyl2,6-dimethyl-4-styryl-1,4-dihydro pyridine-3,5-dicarboxylate  
 
1b  
  
                                       
N
H
COOC2H5
H3C
C2H5OOC
CH3
OCH3
OCH3
  
Diethyl4-(3,4-dimethoxyphenyl)2, 6-dimethyl- 1,4-dihydropyridine3,5- dicarboxylate. 
  
1c     
                   
N
H
COOC2H5
H3C
C2H5OOC
CH3
Cl
Cl
 
Diethyl4-(2,4-dichloro phenyl)- 2,6-dimethyl- 1, 4 –dihydropyridine-3,5-dicarboxylate. 
 
1d  
                         
N
COOC2H5
H3C
C2H5OOC
CH3
CH3
H  
Diethyl 2, 6-dimethyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylate  
  
1e  
                               
N
COOC2H5
H3C
C2H5OOC
CH3
OH
H
OCH3H3CO
 
Diethyl4-(4-hydroxy-3, 5-dimethoxy-2-phenyl)-2, 6-dimethyl-1,4dihydro pyridine-3, 5-dicarboxylate  
 
2a  
                                      
COOH
N
COOC2H5
H3C
C2H5OOC
CH
CH
H2C N
H
CH3
 
4-((3,5-bis(ethoxycarbonyl)-2,6-dimethyl-4-styrylpyridine-1(4H)-yl)methylamino)benzoic acid. 
  
2b  
                                  
N
H2C
COOC2H5
H3C
C2H5OOC
N
CH3
H
COOH
OCH3
OCH3
 
4-((3,5-bis(ethoxycarbonyl)-2,6-dimethyl-4-(3,4-dimethoxy phenyl)pyridine-1(4H)-yl) methylamino) 
benzoic acid.  
2c  
                                               
COOH
N
COOC2H5
H3C
C2H5OOC
CH3
Cl
Cl
H2C N
H
 
4-((3,5-bis(ethoxycarbonyl)-2,6-dimethyl-4-(3,4dichlorophenyl)pyridine-1-(4H)-yl)methyamino) benzoic 
acid.  
  
  
2d  
                       
COOH
N
COOC2H5
H3C
C2H5OOC
CH3
CH3
H2C N
H
 
4-((3,5-bis(ethoxycarbonyl)-2,6-dimethyl-4-p-tolylpyridine-1-(4H)-yl)  
methylamine)benzoic acid.  
2e  
                               
N
COOC2H5
H3C
C2H5OOC
CH3
OH
OCH3H3CO
COOHH2C N
H
 
4-(3,5-bis(ethoxycarbonyl)2,6-dimethyl-4-(4hydroxy3,5dimethoxypheny)pyridine-1 -
(4H)-yl) methylamino)benzoic acid. 
  
CHARACTERIZATION 
 The synthesized compounds were purified by recrystallization and thin layer 
chromatography. The compounds were then subjected to spectral characterization and 
elemental analysis. 
 The melting point was determined by open capillary tube method and it was 
uncorrected. Analysis was performed in Heraceus CHN Rapid analyzer (division of 
catalysis and kinetics, Department of Chemistry, Indian Institute of Technology, 
Chennai,). The data is presented in Table 2. 
 IR Spectra was recorded (KBr) on ABB BOMEM FTIR spectrophotometer MB 
serial II–Canada (Mical Lab, Chennai-32). The data is presented in  
Table 4. 
  1H NMR  Spectrum (DMSO) was recorded on 400 MHZ-Joel DPX (Indian 
Institute of Technology, Chennai, Tamil Nadu, India) using tetra methyl Silane as 
internal standard. The data is presented in a Table 6. 
 Mass spectra were recorded on Joel GC mate-II, GCMS system (Sophisticated 
Analytical Instrument facility, Indian Institute of Technology, Chennai, Tamil Nadu). 
The data is presented in a Table 5. 
  
Table 2 
Various substitution and physicochemical property of dihydropyridine 
derivatives 
Compound R RF   value M..P ( оC) % Yield 
1a C8H7 0.69 131-132 65 
1b 3,4-OCH3-C6H4 0.62 126-128 68 
1c 2,4-Cl – C6H4 0.71 123-125  67 
1d 4-CH3-C6H4 0.23 146-149 70 
1e 2-OCH3-4-OH-
5-OCH3-C6H2 
0.7 120-125 63 
2a C8H7 0.31 123-124 62 
2b 3,4-OCH3-C6H4 0.39 131-135 63 
2c 2,4-Cl-C6H4 0.67 145 62 
2d 4-CH3-C6H4 0.71 148-155 65 
2e 2-OCH3-4-OH-
5-OCH3-C6H2 
0.20 125-134 60 
 
Mobile phase Hexane: Ethyl acetate (2:1)  
  
Table 3 
Elemental analytical data of synthesized compounds 
Elemental analysis 
Calculated (Experimental) Compound Mol. Formula Molecular Weight Yield in percentage 
C H N O 
1a C29H32N2O6 355.43 65 70.96 7.09 3.94 18.01 
1b C28H32N2O7 389.44 68 64.16 5.83 3.86 17.64 9
1c C27H28N2O6Cl2 361.64 67 62.90 5.83 3.86 17.64 9
1d C28H32N2O6 343.42 70 69.95 6.72 3.45 27.62 
1e C29H34N2O9 450.16 63 62.21 6.71 3.45 27.62 
2a C29H32N2O6 504.57 62 69.03 6.39 5.55 19.03 
2b C28H32N2O7 508 63 64.67 6.36 5.29 23.76 
2c C27H28Cl2N2O6 510.70 62 59.24 5.16 5.12 17.54 1
2d C28H32N2O6 492 65 68.28 6.55 5.69 19.49 
2e C29H34N2O9 554 60 62.81 6.18 5.05 25.96 
  
Table 4   
IR spectra of the compounds 
S.No. COMPOUNDS WAVE NUMBER (cm-1) 
1 1a 3369,3173,1648,1587,1465,1443,1396,1315,1300, 1283,1147,1069,724,694. 
2 1b 3348,2982,2715,1776,1746,1669,1589,1388,1234,1198,712,518,478. 
3 1c 3380,2696,2062,1621,1466,1400,1269,693,505. 
4 1d 3409,3199,1649,1581,1444,1393,1315,1298,1282,1067,842,724,694. 
5 1e 3667,3643,3624,3606,3582,3541,3497,3457,3440,3026,1744,1728,1712,1694,1681536, 1445,1393,1283. 
6 2a 3177,2053,1776,1665,1590,1509,1399,1371,1263,1231,1200,713,673,476. 
7 2b 3333,1651,1605,1580,1511,1475,1443,1360,1280,1217,1166,567. 
8 2c 3464,3172,3062,2976,1721,1662,1579,1530,1447,1346,1234,1150,928,830,735,56
9 2d 3365,3267,3166,2061,1647,1587,1466,1444,1393,1299,1283,1068,724,693. 
10 2e 3369,3173,1648,1582,146,1443,1396,1315,1300,1283,1147,694. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig,1 IR Spectra of compound-1a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig,2 IR Spectra of compound-1b 
 
 
 
 
  
Fig,3 IR Spectra of compound-1c 
 
 
 
 
 
 
Fig,4 IR Spectra of compound-1d 
 
 
 
  
 
 
Fig,5 IR Spectra of compound-1e 
 
 
  
 
 
Fig,6 IR Spectra of compound-2a 
 
 
  
 
Fig,7 IR Spectra of compound-2b 
  
Fig,8 IR Spectra of compound-2c 
 
                                                                           
  
Fig,9 IR Spectra of compound-2d 
 
 
  
 
Fig,10 IR Spectra of compound-2e 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 5  
MASS spectral data of the synthesized compounds 
S.No. Compounds Molecular Weight M/Z (%Relative Abundance) 
1 1a 355.43 355.58 M+ (5%), 353.55(10%), 340.51(4%),  326.52(6%),  308.58(5%
252.50(25%),  236.49(8%),  215.44(6%), 206.45(7%). 196.43(8%),  
2 1b 389.44 387.66M+(57%), 278.52(5%), 263.50(6%), 252.51(5%) ,16
95.35(50%),77.32(38%),65.31(18%),  
3 1c 361.64 362.50M+(5%), 286.60(20%), 270.63(5%), 251.46(100%), 
205.40(40%), 175.29(40%), 58.29(10%). 
4 1d 343.42 343.65M+(5%), 312.62(6%), 270.60(18%), 252.57(99%), 2
145.42(20%).\, 119.40(38%), 65.33(18%),  
5 1e 450.16 450.65M+(3%), 438.49(4%), 376.64(4%), 332.57(8%), 314.69(5%
252.57(20%), 224.49(15%), 196.45(18%), 77.32(5%). 
6 2a 504.57 504.92M+(3%),467.70(3%),252.51(58%),236.51(18%),196.43(20%)
61.29(50%), 
7 2b 508 508.37M+(18%), 475.30(20%), 455.53(18%), 398.58(16%
316.60(18%),264.46(12%),252.57(55%), 149.39(25%),137.37(55%)
8 2c 510.70 511.37M+(7%),483.07(7%),358.13(7%),299.56(5%),251.46(32%),22
205.40(15%),75.36(15%),120.43(8%), 83.36(9%).                             
9 2d 492 492.81M+(3%), 341.60(8%), 252.54(98%), 224.49(19%),  
120.39(70%), 65.32(35%0. 
10. 2e 554 555.87M+(%), 527.67(9%), 403.59(18%), 372.22 (18%), 
232.57(98%), 224.54(22%), 154.41(22%), 137.42 (52%), 120.40 (90
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig-11 MASS Spectra of  Compound- 1a 
 
 
Fig-12  MASS Spectra of  Compound- 1b 
  
Fig-13  MASS Spectra of  Compound- 1c 
 
  
 
Fig-14  MASS Spectra of  Compound- 1d 
  
Fig-15  MASS Spectra of  Compound- 1e 
  
 
Fig-16  MASS Spectra of  Compound- 2a 
  
Fig-17  MASS Spectra of  Compound- 2b 
  
Fig-18  MASS Spectra of  Compound- 2c 
  
Fig-19  MASS Spectra of  Compound- 2d 
  
Fig-20  MASS Spectra of  Compound- 2e 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 6  
 
1HNMR Spectral data of the synthesized compounds 
 
mpounds Nature of proton 
Aromatic 
proton  
(A r –H)  (m) 
N=CH-
Ar(s) 
-CH3  
(s) 
C-O-
CH3(s) 
Ar-OH N(CH3)2(s) 
-OCH3
(s) 
-NH2
(s) 
To
No
pro
1a No. of protonδ value (ppm) 
5H 
7.14-7.30 
- 
2H 
1.71 
- - - - - 7
1b No. of protonδ value (ppm) 
5H 
114.1-149.7 
- 
2H 
16.3 
- - - 
2H 
56.2 
- 9
1c No. of protonδ value (ppm) 
4H 
4.43-7.16 
- 
2H 
1.71 
- - - - - 6
1d No. of protonδ value (ppm) 
2H 
4.43-6.94 
- 
3H 
1.71-2.35 
- - - - - 5
 
1e 
No. of protonδ 
value (ppm) 
2H 
5.96 
- 
2H 
1.71 
- - - - - 4
2a No. of protonδ value (ppm) 
9H 
6.87-7.30 
- 
2H 
1.71 
- - - - - 1
2b No. of protonδ value (ppm) 
7H 
6.46-8.05 
- 
2H 
1.71 
- - - 
2H 
3.73 
- 1
2c No. of protonδ value (ppm) 
7H 
6.94-8.05 
- 
2H 
1.71 
- - - - - 9
2d No. of protonδ value (ppm) 
8H 
6.87-8.05 
- 
3H 
1.7-2.78 
- - - - - 1
2e No. of protonδ value (ppm) 
6H 
5.96-8.05 
- 
2H 
1.71 
- 
1H 
5.0 
- 
2H 
3.73 
- 1
 
 
 
  
Fig.-21 1H NMR Spectra of compound 1a 
 
 
 
 
 
Fig.-22 1H NMR Spectra of compound 1b 
 
 
  
 
 
 
 
Fig.-23 1H NMR Spectra of compound 1c 
 
 
  
 
 
 
 
Fig.-24 1H NMR Spectra of compound 1d 
 
 
  
 
Fig.-25 1H NMR Spectra of compound 1e 
 
  
 
 
 
 
Fig.-26 1H NMR Spectra of compound 2a 
 
 
 
  
 
 
Fig.-27 1H NMR Spectra of compound 2b 
 
 
 
  
 
 
Fig.-28 1H NMR Spectra of compound 2c 
 
 
 
  
 
 
Fig.-29 1H NMR Spectra of compound 2d 
 
 
 
  
 
 
Fig.-30 1H NMR Spectra of compound 2e 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PHARMACOLOGICAL EVALUATION 
INVITRO ANTI-OXIDANT ACTIVITY 
 Antioxidants36 are substances whose presence in relatively low concentration 
significantly inhibits the rate of oxidation of the major targets of oxidative activity viz., 
cell membranes and components, proteins and other cellular constituents. 
 Potential role of anti-oxidant in preventing the two important causes of premature 
death, cardiovascular diseases and cancer is partly attractive synthesis of some novel 1, 4-
dihydro pyridine by using Biginelli condensation one pot-multi component reaction 
which are emerged as a novel anticancer agents. 
ANTI-OXIDANT STUDIES 
 FREE RADICAL SCAVENGING ACTIVITY BY NITRIC OXIDE 
SCAVENING METHOD37 
Chemicals used 
                       - Sodium nitro prusside  
                       - Phosphate buffer 
                       - Methanol 
                       - Griess reagent 
Procedure 
 Nitric oxide scavenging activity was measured by spectrophotometry method. 
Sodium nitroprussicle (5mmol) in phosphate-buffered saline was mixed with a control 
test compound, but with an equivalent amount of methanol. Test solution at different 
concentrations (5- 100 mg/ml) were dissolved in methanol and incubated at 250c for 
30mts. After 30min, 1.5ml of the incubated solution was removed and diluted with 1.5ml 
of griess reagent (1% sulphanilamide, 2% phosphoric acid, 0.1% naphthyl 
  
ethylenediamine hydrochloride). The absorbance of the chromophore formed during the 
diazotization of the nitrite with sulphanilamide and the subsequent coupling value is the 
concentration of sample required to inhibit 50% of nitric oxide radical all determinations 
were performed in triplicates % inhibition of nitric oxide radical was calculated by 
following formula. 
          Acont – Atest         
 Nitric oxide scavenged (%)  =       x 100  
                                                                      Acont                         
Where,  
         A cont is the absorbance of the control reaction mixture. 
         A test is the absorbance of the control sample of the synthesized compounds at 
different concentrations. 
The antioxitdant activity of the synthesized compounds was expressed as IC50Values. 
Hydroxyl radical scavenging activity38 
Chemicals used 
¾ EDTA 
¾ Fecl3    
¾ H202  
¾ Thio barbituric acid 
¾ Tri chloro acetic acid 
¾ Distilled water 
¾ Ascorbic acid 
¾ Deoxy ribose 
¾ Phosphate buffer 
  
  
Procedure 
 The scavenging capacity for hydroxyl radical was measured according to the 
modified method. The assay was performed by adding 0.1 ml EDTA, 0.01 ml Fecl3, 0.1ml 
H202 ,  0.36ml of deoxy ribose. 1.0ml of test solutions (5 – 100 kg/ml) dissolved in 
distilled water,0.33ml of phosphate buffer (50mm, pH 7.4), and 0.1ml of ascorbic acid in 
sequence. The mixture was then incubated at 370 for 1 hour. A 1 ml portion of the 
incubated mixture was mixed with 1 ml of 10% TCA and 1 ml of 0.5% TBA to develop 
the chromogen which was measured at 532nm. BHT was used as a positive control.  
% inhibition of hydroxyl radical was calculated by following formula. 
         Acont – Atest         
Hydroxyl radical scavenged (%)    =       x 100   
                                                                     Acont                          
Where, 
       Acont   is the absorbance of the control reaction mixture. 
       A test is the absorbance of sample of the synthesized compounds at different 
concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 7       
  In Vitro Nitric oxide scavenging activity of compounds  
%RSC S. 
No. Compounds 25μg/ml 50μg/ml 75μg/ml 100μg/ml 
IC50 
1 1a  7.15±0.07 13.59±0.09 22.61±0.13 39.02±0.01 >100 
2 1b 18.71±0.25 29.00±0.32 40.19±0.08 51.00±0.001 98.03
3 1c 14.86±0.23 28.57±0.09 39.48±0.12 50.30±0.19 99.22
4 1d 19.43±0.14 30.22±0.1 43.00±0.37 54.22±0.23 92.21
5 1e 26.39±0.12 52.79±0.2 72.28±0.19 82.00±0.09 47.35
6 2a 13.28±0.12 27.86±0.09 38.27±0.2 51.82±0.3 96.48
7 2b 16.90±0.08 31.00±0.019 44.08±0.13 66.12±0.09 75.62
8 2c 31.71±0.07 50.64±0.12 67.95±0.19 81.00±0.24 49.36
9 2d 34.00±0.09 59.81±0.21 73.39±0.25 84.56±0.16 41.79
10 2e 40.43±0.23 65.28±0.13 78.80±0.09 90.73±0.24 38.29
 
 
  
Table 8      
 In Vitro Hydroxyl scavenging activity of compounds  
%RSC S. 
No. Compounds 
25μg/ml 50μg/ml 75μg/ml 100μg/ml 
IC50 
1 1a 10.23±0.12 20.32±0.32 34.19±0.10 49.12±0.01 >100 
2 1b 17.71±0.21 28.59±0.32 39.19±0.83 50.00±0.83 100 
3 1c 10.49±0.02 19.96±0.4 33.83±0.09 51.96±0.1 51.66 
4 1d 16.90±0.28 30.69±0.42 43.18±068 58.12±0.1 86.02 
5 1e 23.28±0.56 67.86±0.35 79.27±0.81 92.82±0.3 36.84 
6 2a 18.63±0.25 29.60±0.32 42.00±0.08 51.00±0.001 98.03 
7 2b 19.43±0.14 31.22±0.1 48.36±0.34 62.22±0.28 80.36 
8 2c 32.92±0.05 62.83±0.12 73.19±0.10 81.31±0.20 39.78 
9 2d 38.23±0.03 65.19±0.17 75.28±0.3 84.31±0.9 38.34 
10 2e 53.77±0.24 66.41±0.37 79.07±0.19 89.92±0.2 23.24 
 
  
 
 
 
ANTIMICROBIAL ACTIVITY 
Antibacterial Evaluation39 
 The antibacterial activity of different sample is done in disc diffusion method 
against the following organisms as directed by Ellen Jo Boron. 
   Escherichia coi   - Gram negative 
   Pseudomonas aeruginosa   - Gram negative 
   Bacillus cereuves   - Gram positive 
   Staphylococus auereus  - Gram positive 
   Media employed   - M.H.AGAR 
   Solvent control Used  - Dimethyl Sulfoxide  
Test Samples 
1a Diethyl2,6-dimethyl-4-styryl-1,4-dihydro pyridine-3,5-dicarboxylate. 
1b Diethyl 4-(3, 4-dimethoxy phenyl) 2, 6-dimethyl-1, 4-dihydropyridine3,5-
dicarboxylate. 
1c Diethyl4-(2,4-dichloro phenyl)- 2,6-dimethyl- 1, 4 –dihydropyridine-3,5-
dicarboxylate. 
   1d Diethyl 2, 6-dimethyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylate 
1e Diethyl4-(4-hydroxy -3, 5-dimethoxy-2-phenyl)-2, 6-dimethyl-1,4dihydro 
pyridine-3, 5-dicarboxylate 
2a 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4-styryl pyridine-1(4h)-               
yl)methylamino)benzoic acid   
  
2b 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4- (3,4-dimethoxy 
phenyl)pyridine-1(4H)-yl) methylamino) benzoic acid. 
2c 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4- (3,4dichlorophenyl)pyridine-
1(4H)- yl) methyamino) benzoic acid 
2d  4-((3,5-bis(ethoxy  carbonyl)-2,6-dimethyl-4-p-tolyl pyridine-1(4 H)-
yl)methylamino) benzoic acid. 
2e 4-(3,5-bis(ethoxy carbonyl)2, 6-
dimethyl(4hydroxy3,5dimethoxypheny)pyridine1(4H)-
yl)methylamino)benzoic acid. 
Standard Used   - Ciprofloxacin  
 The test samples used in concentration 1 mg / µl using dimethyl sulfoxide as 
solvent and 1mg/μl using their respective solvent Gentamicin, Ciprofloxacin and 
Tetracycline were used as standards for  Staphylococus auereus and Escherichia coli. 
Preparation of Media 
Preparation of Nutrient agar 
Peptone      - 0.5% 
Sodium chloride   - 0.5% 
Meat of beef extract              - 0.5% 
Agar     - 3.0% 
Distilled water               - q.s 
pH adjusted to    - 7.2-7.4 
 Then the media is distributed in 5ml quantity into culture tubes and sterilized by 
autoclaving. 
DISC DIFFUSION METHOD  
  
 To the serile nutrient agar suspension of E.coli was added to 45оC and transferred 
to sterile petri  dishes and allowed to solidify .sterile discs 5 mm in diameter  (made for 
what man filter paper sterilized in isopropyl alcohol) dipped in solution containing 
compound  samples and standard and blank paced on surface of agar plates. 
 Leave the plates standing for one hour at room temperature as a period of 
preincubation diffusion to minimize the effect of variation in time between the 
application different solutions. Then the plates were incubated at 37 оC for 18 hrs and 
observed for anti bacterial activity. The diameters of zones of inhibition were measured 
for plates in which zone of inhibition was observed and presented in  
Table 9. 
  The average area of zone of inhibition was calculated and compared with that of 
standard. 
 A similar procedure was carried out for studies of anti-bacterial activity of other 
sample against staphylococcus auereus, the results were tabulated in Table 9.  
ANTIFUNGAL EVALUATION39 
 The antifungal activities of different samples were done in disc diffusion method 
against the following  organism as described by Ellen Jo Boron. 
1)   Aspergillus niger 
2)   Candida albicans 
Media employed         - savouraud  dextrose agar media 
Solvent control used   - dimethyl sulfoxide 
 The sample used in 1mg/µl concentration, using dimethyl sulfoxide  as solvent 
and 1mg/µl concentration using their respective solvent Ketoconozole were used as 
standard against Aspergillus niger. 
  
  
Test Samples 
1a Diethyl2,6-dimethyl-4-styryl-1,4-dihydro pyridine-3,5-dicarboxylate. 
1b Diethyl 4-(3, 4-dimethoxy phenyl) 2, 6-dimethyl-1, 4-dihydropyridine3,5-
dicarboxylate. 
1c Diethyl4-(2,4-dichloro phenyl)- 2,6-dimethyl- 1, 4 –dihydropyridine-3,5-
dicarboxylate. 
   1d Diethyl 2, 6-dimethyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylate 
1e Diethyl4-(4-hydroxy -3, 5-dimethoxy-2-phenyl)-2, 6-dimethyl-1,4dihydro 
pyridine-3, 5-dicarboxylate 
2a 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4-styryl pyridine-1(4h)-               
yl)methylamino)benzoic acid   
2b 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4- (3,4-dimethoxy 
phenyl)pyridine-1(4H)-yl) methylamino) benzoic acid. 
2c 4-((3,5-bis(ethoxy carbonyl)-2,6-dimethyl-4- (3,4dichlorophenyl)pyridine-
1(4H)- yl) methyamino) benzoic acid 
 2d  4-((3,5-bis(ethoxy  carbonyl)-2,6-dimethyl-4-p-tolyl pyridine-1(4 H)-
yl)methylamino) benzoic acid. 
2e 4-(3,5-bis(ethoxy carbonyl)2, 6-dimethyl 
(4hydroxy3,5dimethoxypheny)pyridine1(4H)-yl)methylamino)benzoic 
acid. 
Standard used            Ketoconozole 
Preparation of Media used 
Savouraud Dextrose Agar medium                            gm/l 
Mycological procedure                                              10 
Dextrose                                                                     40.0 
Agar                                                                           15.0 
  
Final pH                                                                     at 25oC 5.6 ± 0.2 
DISC DIFFUSION METHOD 
 Suspensions of Aspergillus niger were added to sterile nutrient agar at 45оC the 
mixture was transferred to sterile petri dishes and allowed to solidify .sterile discs 5 mm 
in diameter (made for what man filter paper sterilized in U.V lamp) dipped in solution 
containing compound samples and standard and blank paced on surface of agar plates. 
 Leave the plates standing for one hour at room temperature as a period of 
preincubation diffusion to minimize the effect of variation in time between the 
application different solutions. 
 The average area of zone of inhibition was calculated and compared with that of 
the standards and the results were tabulated 9. 
Table 9 
Antimicrobial activity of synthesized 1,4-dihydropyridine derivatives 
S. 
No. Compound 
Antibacterial activity zone of inhibition 
(MM) 
Antifungal 
activity zone of 
inhibition (MM 
  B.cereus S.auereus E.coli P.aeruginosa C.albicans A.niger 
1 1a 14 12 13 - 12 18 
2 1b 17 - - 14 13 14 
3 1c 13 15 17 17 15 19 
4 1d 20 16 19 16 16 18 
5 1e - - 17 12 12 17 
6 2a 13 - 14 - 19 16 
7 2b 24 19 15 20 17 14 
8 2c 25 12 18 18 16 19 
9 2d 18 - 17 - 14 15 
10 2e 14 16 - 19 18 17 
  
11 Ciprofloxacin 30 30 28 28 - - 
12 Ketikonazale - - - - 31 30 
Fig. 31  Antibacterial activity of synthesised compounds 1a – 2e 
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BC = Bacillus Cereus   EC = Escherichia Coli 
SA =  Staphylococcus auereus  PA = Pseudomonas Aeruginosa 
Fig. 32  Antifungal activity of synthesised compounds 1a – 2e 
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CA = Candida Albicans    AN = Aspergillius Niger 
 
Photograph showing the effect of Cpd 1d against S.auereus and A.niger 
 
  
 
Photograph showing the effect of Cpd 2d against S.auereus and A.niger 
  
 
Photograph showing the effect of Cpd 2c against S.auereus and A.niger 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
RESULT S AND DISCUSSION 
 I have synthesized the 1, 4 dihydro pyridine derivatives with 65-70 % yield. It 
was further converted as substituted mannich base of 1, 4- dihydro pyridine derivative 
with an of 70-80% yield. 
 The melting point of all synthesized compounds was found in open capillary tubes 
and readings were uncorrected .the elemental analysis was determined and the results 
were tabulated in the Table 3. The found value of the element by elemental analysis 
closer to calculated values 
 The IR spectra of the compounds were done in a schimadzu FT 8300 infrared 
spectrophotometer (Vmaxcm-1) by using KBr discs. The results of IR spectra given in 
the Table 4 shows that the functional groups such as phenolic hydroxyl, ,chlorine, amine, 
phenyl  and methoxy groups may be present in the synthesized compound. 
 The 1HNMR spectra of the synthesized 1, 4-dihydropyridine derivative were 
recorded on JEOL GSX 400 spectrometer using TMS as internal standard (chemical 
shifts in δ, ppm) and DMSO as the solvent The results of the 1HNMR spectra given in 
Table 6 shows that the numbers of hydrogen atoms present in all the synthesized 
compounds were exact when compared to the number of hydrogen atoms in the expected 
compounds. 
 The Mass spectra of the all synthesized compounds were done on a JEOL 
MSMATE spectrometer. The results were presented in Table 5 show that molecular mass 
of the synthesized compounds were nearer to the molecular mass of expected 
compounds.  
  The synthesized compounds were screened for there in vitro antioxidant activity 
by Nitrous oxide, Hydroxyl radical scavenging activity. The results obtained were 
tabulated in Table 7, 8 were given as mean IC50. All the synthesized compounds showed 
good anti-oxidant activity, out of all the synthesized compounds 1e, 2c, 2d, 2e showed 
  
significant anti-oxidant activity, in all the method except the compound 1a which showed 
less when compared to that of the standard butylated hydroxyl toluene (BHT). 
  The bleaching of Nitric oxide, hydroxyl ion absorption is representative of the 
capacity of the test compounds to scavenging free radical independently. The result of my 
investigation revealed that the test compound is electron donor and could react with free 
radicals to convert them to more stable product and terminate radical chain reaction. 
 The compound (1e, 2c, 2d, 2e) substituted with electron donating groups like 
methoxy and hydroxyl showed higher anti-oxidant activity compared to others. 
The synthesized compounds were screened for their anti-microbial activity by 
Disc diffusion method. The results were tabulated in Table 9. The results showed that the 
compounds 1d, 2b 2c having very good activity when compare that of standard drug 
(ciprofloxacin). Because of the presence of methoxy group in 3&4th position (2b), 
similarly (2c) presence of chlorine in 2&4th position and presence of methyl group in p-
position (1d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SUMMARY AND CONCLUSION 
 Molecular modification of simple and complex chemical entities may lead to 
biological active compounds. Different types of approaches are made to derive such 
compounds which exhibit selective pharmacological activity. Pyridine and their related 
compounds exhibited potent antioxidant and antimicrobial activity.  
 This research work was oriented   towards the finding of newly 1, 4-dihydro 
pyridine derivatives with antioxidant and anti microbial activities. The different 
substitution of some 1, 4- dihydro pyridine was synthesized by aromatic aldehydes and 
ethyl acetoacetate followed by condensation reactions. Ten compounds have been 
synthesized and all the compounds were tabulated.  
 Using different analytical techniques, elemental analysis, IR 1HNMR and mass 
spectroscopes. The results of this analysis showed that the expected different substituted 
some dihydro pyridine derivative were prepared. 
 The newly synthesized some dihydro pyridine derivatives were evaluated for their 
antioxidant and antimicrobial activity. The synthesized compounds 1e,1c,2d,2e showed  
effective antioxidant activity, also all the compound expect compound 1d.2b,2c was 
found to exhibit good antimicrobial activity . This clearly indicates that new dihydro 
pyridine derivatives can be effectively synthesized by the method mentioned in this study 
and these compounds exhibited significant antimicrobial and anti oxidant activities. 
FUTURE PLAN  
 In conclusion, the present study reveals that some 1,4-dihydropyridine derivatives 
could be used as template for the future development through modification or 
derivatization to design more potent therapeutic agents. 
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